期刊文献+

培菲康临床应用进展 被引量:19

Development of Birid Triple Viable (BIFICO) for clinical application
下载PDF
导出
摘要 (第二军医大学药学院药理教研室上海200433)摘要目的:介绍三联活菌制剂“培菲康”的临床研究与应用。方法:查阅国内外文献,并进行分析、归纳和综述。结果:“培菲康”临床应用广泛,对儿童腹泻、儿童功能性便秘、新生儿黄疸、肠易激综合征等有肯定疗效;对儿童厌食症、肝硬化、幽门螺旋杆菌感染、儿童单纯性肾病综合征等有很好疗效。结论:“培菲康”具有重要的临床意义,随着研究的深入,其临床应用将有更大的发展空间和潜力。 Aim :To introduce the clinical researches on Birid Triple Viable (BIFICO) and its application area. Methods: Domestic and foreign publications documenting clinical effects of BIFICO were retrieved, analyzed, and summarized. Results: BIFICO was widely used in clinical practice. It had definite effects on children's diarrhea, children' s functional constipation, neonatal jaundice, and irritable bowel syndrome and had good effect on children' s anorexia, liver cirrhosis, Helicobacter pylori infection, children' s simple nephritic syndrome. Conclusion : BIFICO has great clinical significance. Intensive studies will provide more potential and space for the development and clinical application of BIFICO.
作者 阎澜 张军东
出处 《上海医药》 CAS 2007年第3期114-116,共3页 Shanghai Medical & Pharmaceutical Journal
关键词 培菲康 临床研究 临床应用 Birid Triple Viable clinical study clinical application
  • 相关文献

参考文献23

二级参考文献68

共引文献106

同被引文献167

引证文献19

二级引证文献224

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部